Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
LEXINGTON, Mass., July 3, 2013 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), an oncology-focused company seeking to develop next generation targeted drug candidates for cancer treatment, today announced that on July 9, 2013 the Company will participate in the Piper Jaffray Catalyst Symposium in Boston and on July 10, 2013, Dan Passeri, Chief Executive Officer, will present a corporate overview at the 8th Annual JMP Securities Healthcare Conference in New York City. Details of these two events are as follows:
Help employers find you! Check out all the jobs and post your resume.
